5e93158a6b6b2.pdf
DOI:
Mavjud emas
1. Тоиров Э. С. Диагностика и лечение погранич-ных 29. нервно-психических нарушений у больных с ревматическими заболеваниями: методические рекомендации //Ташкент.-2004.-18 с. 2. Singh J. A., Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans II Ann. Rheum. Dis. - 2008. V. 67. P. 1310-1316. 3. Andrusha A.B. Podagra ta giperurykemiia: ne-typovyi perebig chy suchasne oblychia? Ukraiinskyi terapevtychnyi gurnal. - 2014. - № 1., s. 23. 4. Roddy E. Epidemiology of gout. E. Roddy, M. Doherty. Arthritis Research & Therapy. - 2010. - V. 12, N 6. - P. 223-234. 5. Paliienko I. A. ta inshi, Ryzyk - faktory kardiovaskuliarnyh uragen pry podagri. Ukraiinskii revmatologichnyi gurnal, 2013 r. N 3. - s. 143 - 144. - 2013; 6. Lebedeva M. V. Optimizaciia antigipertenzivnoy terapiii i funkcyia endoteliia u bolnyh podagroi i hronicheskim uratnym tubulointersticialnym nefritom. Terapevticheskii arhiv. - 2010. - № 6. - s. 43 - 46. 7. Soriano L. С Contemporary epidemiology of gout in the UK general population. Arthritis Research & Therapy. - 2011. - V. 13, N 6. - P. R39 - R48.